Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier ...

The National Institute for Health and Care Excellence (NICE) has recommended Santhera Pharmaceuticals’ Agamree (vamorolone) to treat Duchenne muscular dystrophy (DMD). The drug has been recommended ...

Johnson & Johnson (J&J) has shared positive data from a late-stage study of its subcutaneous CD38-directed antibody Darzalex ...

EU Lab Day 2024 made an impact – reaching over 1.7million people through media and social. EatMoreFruit recently helped ...

Roche has shared new long-term results from a phase 3 study of its anti-CD79b antibody-drug conjugate Polivy (polatuzumab ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Sanofi has presented promising results from a phase 3 study of its investigational oral Bruton’s tyrosine kinase (BTK) ...

Of the patients in the poze-cemdi group, 93% achieved LDH normalisation across study visits on average, compared to 65% of ...

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...

From animation and gamification, to events, influencers, opinion leaders, and chatbots; there are tools and tactics which can ...

To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business ...

GSK and Rgenta Therapeutics have partnered to develop RNA-targeting small molecule splice modulators for disease areas ...